Suzanne Ildstad
Plus aucun poste en cours
Fortune : 12 M $ au 31/03/2024
Profil
Suzanne T.
Ildstad is the founder of Talaris Therapeutics, Inc. which was founded in 2002.
She held the title of Chief Scientific Officer & Director from 2018 to 2022.
Dr. Ildstad is also the founder of the University of Louisville.
She received her undergraduate degree from the University of Minnesota.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
1,98% | 14/06/2023 | 507 980 ( 1,98% ) | 12 M $ | 31/03/2024 |
Anciens postes connus de Suzanne Ildstad
| Sociétés | Poste | Fin |
|---|---|---|
| University of Louisville | Founder | - |
| TOURMALINE BIO, INC. | Chief Executive Officer | 01/11/2018 |
Formation de Suzanne Ildstad
| University of Minnesota | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
